Prescriber's Corner
Cabazitaxel
Christopher Campen, PharmD, BCPS, and Emad Elquza, MD
From Arizona Cancer Center, Tucson, Arizona
The authors have no conflicts of interest to disclose.
Correspondence to: Christopher Campen, PharmD, BCPS, Arizona Cancer Center–Orange Grove, Tucson, AZ 86704. E-mail: chriscampen@gmail.com
J Adv Pract Oncol 2011;2:191–194 |
DOI: 10.6004/jadpro.2011.2.3.6 |
© 2011 Harborside Press®
For access to the full length article, please
sign in.
